Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07481058
What this trial is testing

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Beijing Konruns Pharmaceutical Co., Ltd. 60
Not applicableLooking for participantsNCT06408584
What this trial is testing

Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 25
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)UnknownNCT03603756
What this trial is testing

SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma
Chinese Academy of Medical Sciences 45
Testing effectiveness (Phase 2)Ended earlyNCT05714553
What this trial is testing

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Who this might be right for
Advanced CancerAdvanced Solid TumorNeoplasm Malignant+14 more
NuCana plc 19
Not applicableUnknownNCT06412419
What this trial is testing

Multimodal Endoscopic Image Fusion for Assessing Infiltration in Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Neoplasms Malignant
Changhai Hospital 450
Testing effectiveness (Phase 2)UnknownNCT05386056
What this trial is testing

Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618910
What this trial is testing

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT06422403
What this trial is testing

A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers

Who this might be right for
Carcinoma, HepatocellularGastric AdenocarcinomaGastroEsophageal Cancer+3 more
National University Hospital, Singapore 360
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06339619
What this trial is testing

Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur, Gimeracil and Oteracil Potassium Capsules for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 32
Not applicableUnknownNCT04514822
What this trial is testing

Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaPositron Emission Tomography
Fifth Affiliated Hospital, Sun Yat-Sen University 40
Large-scale testing (Phase 3)UnknownNCT05213312
What this trial is testing

Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital 90
Early research (Phase 1)Looking for participantsNCT07812805
What this trial is testing

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

Who this might be right for
Selected Advanced Solid TumorsColorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more
SK Life Science, Inc. 100
Large-scale testing (Phase 3)Looking for participantsNCT04280822
What this trial is testing

Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma

Who this might be right for
Esophageal CancerSurgeryNeoadjuvant Treatment+1 more
Henan Cancer Hospital 400
Testing effectiveness (Phase 2)Ended earlyNCT05563272
What this trial is testing

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

Who this might be right for
Cervical CancerColorectal CancerEsophageal Cancer+16 more
Telix Pharmaceuticals (Innovations) Pty Ltd 11
Large-scale testing (Phase 3)Looking for participantsNCT07629817
What this trial is testing

Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital 1,044
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Not applicableEnded earlyNCT02953418
What this trial is testing

RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia

Who this might be right for
Esophageal Squamous Cell Neoplasia (ESCN)
Medtronic - MITG 34
Testing effectiveness (Phase 2)Study completedNCT04785820
What this trial is testing

Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus

Who this might be right for
Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Hoffmann-La Roche 190
Next Page